|
HPV Types
|
Histological Results
|
|---|
|
TOTAL
|
NORMAL(n,%)
|
LSIL(n,%)
|
HSIL(n,%)
|
CA(n,%)
|
HSIL+(n,%)
|
HSIL+OR(95% CI)
|
|---|
|
16
|
1047
|
522 (49.86)
|
169 (16.14)
|
325 (31.04)
|
31 (2.96)
|
356 (34.00)
|
3.576 (2.442–5.238)
|
|
18
|
270
|
175 (64.81)
|
61 (22.59)
|
30 (11.11)
|
4 (1.48)
|
34 (12.59)
|
1
|
|
31
|
40
|
19 (47.50)
|
10 (25.00)
|
11 (27.50)
|
0 (0.00)
|
11 (27.50)
|
2.633 (1.205–5.753)
|
|
33
|
43
|
24 (55.81)
|
8 (18.60)
|
11 (25.58)
|
0 (0.00)
|
11 (25.58)
|
2.386 (1.101–5.172)
|
|
35
|
23
|
14 (60.87)
|
5 (21.74)
|
4 (17.39)
|
0 (0.00)
|
4 (17.39)
|
1.461 (0.469–4.554)
|
|
39
|
65
|
49 (75.38)
|
13 (20.00)
|
3 (4.62)
|
0 (0.00)
|
3 (4.62)
|
0.336 (0.100–1.130)
|
|
45
|
21
|
16 (76.19)
|
4 (19.05)
|
1 (4.76)
|
0 (0.00)
|
1 (4.76)
|
0.347 (0.045–2.670)
|
|
51
|
64
|
44 (68.75)
|
16 (25.00)
|
4 (6.25)
|
0 (0.00)
|
4 (6.25)
|
0.463 (0.158–1.355)
|
|
52
|
183
|
115 (62.84)
|
30 (16.39)
|
38 (20.77)
|
0 (0.00)
|
38 (20.77)
|
1.819 (1.096–3.020)
|
|
53
|
78
|
62 (79.49)
|
15 (19.23)
|
1 (1.28)
|
0 (0.00)
|
1 (1.28)
|
0.090 (0.012–0.670)
|
|
56
|
64
|
41 (64.06)
|
20 (31.25)
|
3 (4.69)
|
0 (0.00)
|
3 (4.69)
|
0.341 (0.101–1.149)
|
|
58
|
136
|
86 (63.24)
|
28 (20.59)
|
20 (14.71)
|
2 (1.47)
|
22 (16.18)
|
1.340 (0.749–2.395)
|
|
59
|
33
|
22 (66.67)
|
10 (30.30)
|
1 (3.03)
|
0 (0.00)
|
1 (3.03)
|
0.217 (0.029–1.639)
|
|
66
|
41
|
29 (70.73)
|
10 (24.39)
|
2 (4.88)
|
0 (0.00)
|
2 (4.88)
|
0.356 (0.082–1.542)
|
|
68
|
48
|
37 (77.08)
|
9 (18.75)
|
2 (4.17)
|
0 (0.00)
|
2 (4.17)
|
0.302 (0.070–1.300)
|
|
Na
|
2156
|
1255 (58.21)
|
408 (18.920
|
456 (21.15)
|
37 (1.72)
|
493 (22.87)
|
–
|
- HPV human papillomavirus
- hr-HPV high-risk human papillomavirus
- LSIL low-grade squamous intraepithelial lesion
- HSIL high-grade squamous intraepithelial lesion
- CA cervical cancer
- HSIL+ high-grade squamous intraepithelial lesion or worse
- OR odds ratio
- CI confidence interval
- a=The total number of women with hr-HPV positive in the corresponding histological results groups
